Cowen and Company’s Cano Health, Inc. CANO Stock Holding History

Cowen and Company’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-989	Closed	-$57K	–	811
2021 Q3	$57K	Buy	+989	New	+$1.2M	﹤0.01%	375

Other funds holding CANO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Cowen and Company's CANO Position: Q2 2023 in Review

Cowen and Company sold out of Cano Health, Inc. (CANO) in Q2 2023, closing a stake of 400 shares — an estimated $36.4K sold.

Cowen and Company first reported a position in CANO in Q3 2020 and held it in 3 quarters. The position peaked at $3.28M in Q3 2021. 154 funds tracked by Wall St. Rank hold CANO as of Q2 2023.

Cowen and Company reported no remaining Cano Health, Inc. position as of Q2 2023 after selling out during the quarter.
Cowen and Company sold 400 Cano Health, Inc. shares in Q2 2023, an estimated $36.4K.
Cowen and Company first reported a position in Cano Health, Inc. in Q3 2020 and held it in 3 quarters.
Cowen and Company's Cano Health, Inc. position peaked at $3.28M in Q3 2021.
154 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.